Hair Loss, Hot Flash Breakthroughs, and the ADHD Connection

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Hair Loss, Hot Flash Breakthroughs, and the ADHD Connection

Listen for free

View show details

About this listen

A systematic review shows estrogen therapy may help with menopausal hair loss. A new non-hormonal drug GS1-144 targets hot flash mechanisms directly. And experts are exploring why ADHD diagnoses are rising in menopausal women as estrogen decline affects dopamine and focus. Key Takeaways: • Estrogen therapy shows promise for menopausal hair loss, but results vary and early treatment seems to work better • GS1-144, a neurokinin 3 receptor antagonist, significantly reduced hot flash frequency and severity in a phase 2 trial • More women in their 40s and 50s are being diagnosed with ADHD for the first time, possibly linked to declining estrogen affecting dopamine • Focus and attention issues that persist despite menopause treatment may warrant an ADHD evaluation Sources & References: • Menopause and hair loss in women: Exploring the hormonal transition (https://pubmed.ncbi.nlm.nih.gov/40318238/) - PubMed • Neurokinin 3 receptor antagonism for menopausal hot flashes (https://pubmed.ncbi.nlm.nih.gov/37541194/) - PubMed • ADHD Diagnoses May Be Rising In Menopausal Women (https://www.huffingtonpost.co.uk/entry/adhd-menopause-link-explained_uk_69ea1477e4b0bb584bc96158) - HuffPost Listen with full show notes: https://hotflasher.com/episodes/2026-04-27-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

No reviews yet